Sleep Architecture Optimisation Protocol
Restore deep slow-wave sleep, normalise circadian rhythm, and leverage sleep-phase GH secretion for recovery and cognitive restoration
Want a personalised protocol?
Our AI generator builds a protocol tailored to your profile and goals.
This protocol is an educational example only. It does not apply to your specific health situation. Medical supervision is required. Peptide therapy is not approved by regulatory bodies for many of the described indications.
Protocol Stack
DSIP
PrimaryDose
100β200 mcg
Frequency
5x/week SC
Timing
20β30 min before desired sleep onset
Duration
6 weeks (5 on / 2 off weekly rhythm)
Epithalon
PrimaryDose
10 mg
Frequency
5x/week SC
Timing
Morning, on waking β circadian anchor
Duration
6 weeks
MK-677
OptionalDose
10 mg oral
Frequency
Daily
Timing
30 min before bed β amplifies sleep-phase GH pulse
Duration
6 weeks (optional; omit if water retention is a concern)
Monitoring Parameters
- βPittsburgh Sleep Quality Index (PSQI) β baseline and week 6
- βSleep tracker data (Oura, WHOOP, or similar) β nightly
- βMorning cortisol β baseline and week 6
- βIGF-1 if MK-677 included β baseline and week 6
- βSubjective energy and cognitive sharpness β weekly self-report
Expected Outcomes
Weeks 1β2: Earlier sleep onset, reduced sleep latency
Weeks 3β4: Increased deep sleep fraction (tracker-confirmed), reduced night waking
Weeks 5β6: Normalised morning energy, improved cognitive performance, reduced cortisol awakening response
Contraindications
- βUndiagnosed or untreated sleep apnoea β deepen sleep without addressing apnoea first
- βMK-677 contraindicated in active malignancy, uncontrolled diabetes (raises fasting glucose), severe fluid retention
- βDSIP β avoid same evening as alcohol or sedative medications
Clinical Notes
DSIP and Epithalon address different sleep mechanisms: DSIP promotes delta-wave generation acutely, while Epithalon works on the pineal gland to restore melatonin rhythmicity over weeks. MK-677's role is to amplify the natural GH pulse that occurs in deep NREM sleep β removed from the protocol, sleep still improves but GH recovery benefit is reduced. For jet lag or shift work, Epithalon timing should be adjusted to the desired local wake time.
Case Study
Clinical Practice Example
Female, 52, perimenopausal. PSQI score 14/21 (severe insomnia). Sleep tracker showed average 42 min deep sleep/night (target >90 min). Hot flushes and cortisol dysregulation confirmed. Protocol: DSIP 150 mcg SC before bed + Epithalon 10 mg SC morning. Week 3: PSQI improved to 9, deep sleep averaging 68 min/night. Week 6: PSQI 6 (near-normal), deep sleep 94 min/night, morning cortisol normalised, subjective energy rated 8/10. MK-677 not used due to pre-existing mild glucose elevation.